MENU
NRXP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

NRX Pharmaceuticals (NRXP) Earnings Date & Reports

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases... Show more

A.I. Advisor
published Earnings

NRXP is expected to report earnings to fall 93.24% to -5 cents per share on May 14

NRX Pharmaceuticals NRXP Stock Earnings Reports
Q1'24
Est.
$-0.05
Q4'24
Missed
by $0.66
Q4'23
Missed
by $0.43
Q3'23
Beat
by $0.04
Q2'23
Beat
by $0.01
The last earnings report on March 14 showed earnings per share of -74 cents, missing the estimate of -7 cents. With 295.33K shares outstanding, the current market capitalization sits at 50.83M.
View a ticker or compare two or three
NRXP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

is a blank check company, which engages in a stock exchange, asset acquisition, stock purchase, and reorganization

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1201 Orange Street
Phone
+1 484 254-6134
Employees
N/A
Web
https://nrxpharma.com